Trial · NCT02655653
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Chest Tube Drainage | 4 hours, 8 hours, 12 hours, 24 hours | Chest tube drainage are collected from the nursing records, every 4th hourly the amount fluid collected is reported in the collection sheets. |
| Primary | Median Amount of Blood Products Used | 24 hours after surgery | Four types of blood products may be given through blood transfusions: whole blood, red blood cells, platelets, and plasma |
| Secondary | Diagnosis of Renal Dysfunction Post-operation | Within 30 days after surgery | Confirmed diagnosis of renal dysfunction and hospitalization for the same within 30 days after the surgery |
| Secondary | Diagnosis of Myocardial Infarction Post-operation | Within 30 days after surgery | Confirmed diagnosis of myocardial infraction and hospitalization for the same within 30 days after the surgery |
| Secondary | Number of Participants Who Have Confirmed Diagnosis of Respiratory Arrest | Within 30 days after surgery | Confirmed diagnosis of respiratory arrest and hospitalization for the same within 30 days after the surgery |
| Secondary | Number of Participants With Confirmed Diagnosis of Stroke | Within 30 days after surgery | Confirmed diagnosis of stroke and hospitalization for the same within 30 days after the surgery |
| Secondary | Number of Participants With Confirmed Diagnosis of Seizure | Within 30 days after surgery | Confirmed diagnosis of seizure and hospitalization for the same within 30 days after the surgery |
| Secondary | Reoperation | Within 30 days after surgery | Confirmed diagnosis of reopeartion and hospitalization for the same within 30 days after the surgery |
| Secondary | Mortality Within 30 Days Post-operation | Within 30 days after surgery | |
| Other | Patient Demographics | Baseline | Measurements taken as a composite. BMI, Sex, Age are to be determined to ensure that the subjects' characteristics were comparable between the Epsilon-aminocaproic Acid and Tranexamic Acid groups. |
| Other | Type of Surgery | Intraoperative | |
| Other | Intraoperative Characteristics | Intraoperative | Measurements are taken as a composite to determine that the subjects' characteristics are comparable between the Epsilon-aminocaproic Acid and Tranexamic Acid groups. Measurements include temperature, Heparin dose, protamine given, time of surgery, time of cardiopulmonary bypass, and aortic clamp time. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02655653/registered